Comment on "The End of Phase 3 Clinical Trials in Biosimilars Development?"
- PMID: 30604391
- DOI: 10.1007/s40259-018-0330-1
Comment on "The End of Phase 3 Clinical Trials in Biosimilars Development?"
Comment on
-
The End of Phase 3 Clinical Trials in Biosimilars Development?BioDrugs. 2018 Aug;32(4):319-324. doi: 10.1007/s40259-018-0287-0. BioDrugs. 2018. PMID: 29943088
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
